Willow

WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA

Retrieved on: 
Wednesday, September 6, 2023
Partnership, TUDCA, Ursodeoxycholic acid, Ascending cholangitis, API, Sandhill, Research, Chemistry, UDCA, TSX, Ursodoxicoltaurine, R, WLLW, ALS, Fine chemical, Willow

Through this partnered program with Sandhill One, LLC ("Sandhill"), Willow has now optimized a proprietary enzyme vital to the development of UDCA while solving for selective C-H hydroxylation at industrial scale - often referred to as one of the "Holy Grails" of chemistry.

Key Points: 
  • Through this partnered program with Sandhill One, LLC ("Sandhill"), Willow has now optimized a proprietary enzyme vital to the development of UDCA while solving for selective C-H hydroxylation at industrial scale - often referred to as one of the "Holy Grails" of chemistry.
  • This breakthrough was made possible by Willow's BioOxi technology, and we believe marks the first example of commercially relevant productivities with this class of enzyme.
  • This successful outcome further illustrates that the BioOxi platform is broadly applicable to the manufacturing of intermediates and APIs, particularly steroid APIs.
  • With R&D now complete, Willow anticipates receiving milestone payments and revenue upon commercialization by Sandhill.

Physical Security Market worth $136.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, September 4, 2023
Partnership, Theft, ACAA, VMS, Software, Law enforcement, General Dynamics, Teledyne Technologies, Willow, ADT, Dahua Technology, Teledyne FLIR, USD, Access control, Government, Axis, Organization, Member of the Scottish Parliament, Cisco Meraki, Acquisition, BAE Systems, HID Global, Physical security, Crime, City, Growth, Market, Safety, Video management system, NEC, Bosch, Hexagon AB, Online shopping, Medical device, Secom, Huawei, Pacific Ocean, Telus, Physical, Cisco, Honeywell

Customers are assisted by managed service providers to maintain their hardware, software, physical security systems, and solutions up to date with the most recent improvements.

Key Points: 
  • Customers are assisted by managed service providers to maintain their hardware, software, physical security systems, and solutions up to date with the most recent improvements.
  • Due to the region's rising crime rate, physical security solutions are quickly gaining popularity across Asia and the Pacific.
  • Smart cities heavily rely on physical security solutions, which is also driving the Physical Security Market in the region.
  • In order to provide a cohesive security ecosystem for more effective monitoring and control, physical security systems can interact with other security and building management systems.

Physical Security Market worth $136.9 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, September 4, 2023
General Dynamics, Acquisition, Crime, Willow, Hexagon AB, Organization, Software, Theft, VMS, ACAA, ADT, USD, Access control, Physical security, Growth, Market, Bosch, Safety, Law enforcement, Teledyne Technologies, Teledyne FLIR, Dahua Technology, Government, Axis, Cisco Meraki, Partnership, Member of the Scottish Parliament, BAE Systems, HID Global, City, Video management system, NEC, Online shopping, Medical device, Huawei, Honeywell, Telus, Secom, Pacific Ocean, Physical, Cisco

Customers are assisted by managed service providers to maintain their hardware, software, physical security systems, and solutions up to date with the most recent improvements.

Key Points: 
  • Customers are assisted by managed service providers to maintain their hardware, software, physical security systems, and solutions up to date with the most recent improvements.
  • Due to the region's rising crime rate, physical security solutions are quickly gaining popularity across Asia and the Pacific.
  • Smart cities heavily rely on physical security solutions, which is also driving the Physical Security Market in the region.
  • In order to provide a cohesive security ecosystem for more effective monitoring and control, physical security systems can interact with other security and building management systems.

WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST

Retrieved on: 
Wednesday, August 30, 2023
Steroid, TSX, Polyphenol, WLLW, Fine chemical, Pharmaceutical industry, Willow

Coupled with pending patent protection, should it be granted, Willow believes this wholly-owned technology will provide a significant competitive advantage to potential pharmaceutical manufacturing partners.

Key Points: 
  • Coupled with pending patent protection, should it be granted, Willow believes this wholly-owned technology will provide a significant competitive advantage to potential pharmaceutical manufacturing partners.
  • "BioOxi is already unlocking valuable revenue growth opportunities in the near-term particularly with corticosteroids, which we believe will be a large-scale market opportunity.
  • We believe the economic value of a Willow-held patent to manufacture at a demonstrably lower cost than current corticosteroid production represents an exciting opportunity for us and our stakeholders."
  • By leveraging BioOxi, commercial partners can revolutionize the manufacturing process of hydroxylated functional ingredients such as steroids, polyphenols, oxyterpenes, and other ingredients.

Willow Innovations Premieres New Docu-Series "Powerviews" To Give An Intimate Look at the Power of Motherhood

Retrieved on: 
Tuesday, August 29, 2023
Learning, Obsession, Chambers, Parent, Temperature, Mother, Milk, Powerview-Pine Falls, Collection, SAN, Lactation, Deedra Irwin, Breast milk, Dairy, Femtech, Cole, Willow

SAN FRANCISCO, Aug. 29, 2023 /PRNewswire/ -- Today, Willow Innovations, Inc. (Willow), the Femtech leader disrupting the pumping and feeding industry, announces the release of a docu-series "Powerviews," an intimate view of real moms as they navigate new motherhood and their feeding journey. The series offers viewers a glimpse into the lives of various mothers who share their authentic experiences, joys, and struggles as they dismantle stereotypical narratives about motherhood.

Key Points: 
  • The series offers viewers a glimpse into the lives of various mothers who share their authentic experiences, joys, and struggles as they dismantle stereotypical narratives about motherhood.
  • "Willow's products, and the stories we tell about motherhood, reflect the honest experience of real moms and parents.
  • We created the first in-bra wearable pump to support breastfeeding in the full context of a mom and woman's life," said Sarah O'Leary, Chief Commercial Officer at Willow.
  • This campaign is an invitation to change the narrative about the new parenthood struggle to one of strength and celebration."

WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM

Retrieved on: 
Thursday, August 24, 2023
San Francisco, Intellectual property, Sustainability Accounting Standards Board, Disclosure, Willow, Sale, Willow Garage, TSX, Growth, WLLW, Fine chemical, Renewable energy, Management, San Francisco Bay Area

Willow has in recent months taken a number of steps to grow revenue and reduce costs.

Key Points: 
  • Willow has in recent months taken a number of steps to grow revenue and reduce costs.
  • The Company has demonstrated executional success on commercial programs, including four new programs related to its BioOxi™ bio-oxidation platform technology launched in April 2023, and is now primarily focusing on partner-funded enzyme engineering engagements.
  • Willow has completed its transition as a San Francisco Bay Area-based biotech company.
  • It has consolidated its operations, transitioning to a single, cost efficient facility in Sunnyvale, California which can accommodate future growth.

Apogee Therapeutics Appoints Mark C. McKenna, Healthcare Veteran and Former Chairman, President and CEO of Prometheus Biosciences, as Chairman of its Board

Retrieved on: 
Monday, August 21, 2023
Prometheus, Ernst & Young Entrepreneur of the Year Award, IPO, University, Bausch Health, Therapy, Senior, Marketing, I&I, Atopic dermatitis, MBA, Antibody, Chronic obstructive pulmonary disease, Bausch & Lomb, Acquisition, Patient, SAN, Arizona State University, Knowledge, Growth, Merck, Merck & Co., AD, Azusa Pacific University, Salix Pharmaceuticals, Management, Apsis, Bausch, Willow

Mr. McKenna’s knowledge and successful track record in the I&I space as well as his significant development, commercial and executive management experience contributed to the Apogee board of directors’ selection decision.

Key Points: 
  • Mr. McKenna’s knowledge and successful track record in the I&I space as well as his significant development, commercial and executive management experience contributed to the Apogee board of directors’ selection decision.
  • “We are thrilled to welcome Mark as chair of our board and to expand our team with such an accomplished biopharma executive and leader,” said Michael Henderson, M.D., Chief Executive Officer of Apogee.
  • “I am honored to join the Apogee team, particularly at this exciting time in the company’s evolution,” said Mr. McKenna.
  • His strategic insights and wealth of experience in guiding companies through all stages will undoubtedly enhance Apogee’s efforts to deliver transformative biologics for patients.”

WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS

Retrieved on: 
Monday, August 21, 2023
TSX, Willow, API, Health, WLLW, Willow Garage, Fine chemical

SUNNYVALE, Calif., Aug. 21, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients, today announced a collaboration with a Nasdaq-listed biopharma company to develop new sustainable manufacturing routes to key intermediates and active pharmaceutical ingredients (APIs).

Key Points: 
  • SUNNYVALE, Calif., Aug. 21, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients, today announced a collaboration with a Nasdaq-listed biopharma company to develop new sustainable manufacturing routes to key intermediates and active pharmaceutical ingredients (APIs).
  • Willow's collaboration partner recognized the need to employ more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste and sought Willow's expertise in developing and scaling key ingredients.
  • The initial program will focus on the feasibility of developing a biobased pathway and, if successful, advance development toward implementation at commercial scale.
  • This agreement represents the 5th new development agreement executed by Willow in 2023, with a robust pipeline of other potential collaborations in process.

MedAvail Reports Second Quarter 2023 Financial Results

Retrieved on: 
Monday, August 14, 2023
Cloud, Patient satisfaction, Texas Health Resources, FQHC, API, Federally Qualified Health Center, Pharmacy, PMS, Google Cloud, Growth, Willow, Rare-earth element, Security (finance)

PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023.

Key Points: 
  • PHOENIX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023.
  • “During the second quarter, we were able to sustain the positive momentum that we have experienced since we began focusing on the immense market opportunity for our pharmacy technology in January of this year,” said Mark Doerr, Chief Executive Officer of MedAvail.
  • Generated second quarter net revenue of approximately $405,000 and placed two net new dispensing MedCenters.
  • MedAvail is today reaffirming its prior guidance for the full year 2023.

WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS

Retrieved on: 
Tuesday, August 8, 2023
Ursodeoxycholic acid, Bank statement, API, San Francisco Bay Area, Willow Garage, SEDAR, UDCA, TSX, WLLW, D, Fine chemical, Willow

SUNNYVALE, Calif., Aug. 8, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ingredients, today released its financial and operating results for the three months ended June 30, 2023, reporting further progress in its commercial expansion.

Key Points: 
  • SUNNYVALE, Calif., Aug. 8, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ingredients, today released its financial and operating results for the three months ended June 30, 2023, reporting further progress in its commercial expansion.
  • Willow's unaudited consolidated interim financial statements and related management's discussion and analysis for the quarter ended June 30, 2023, are available on SEDAR at www.sedarplus.ca .
  • Willow previously announced successful results from utilizing its BioOxiTM bio-oxidation platform for development of a key step for production of this large volume active pharmaceutical ingredient ("API").
  • Willow ended the quarter with approximately $6.5 million of cash as of June 30, 2023.